2023 - Research.com Medicine in Germany Leader Award
His research brings together the fields of Adverse effect and Internal medicine. In his study, Stefan Zeuzem carries out multidisciplinary Virus and Hepatitis B virus research. His study deals with a combination of Hepatitis B virus and Virus. His study connects Cirrhosis and Gastroenterology. His research on Cirrhosis frequently connects to adjacent areas such as Gastroenterology. Stefan Zeuzem integrates many fields in his works, including Hepatitis C virus and Hepacivirus. He conducts interdisciplinary study in the fields of Hepacivirus and Hepatitis C virus through his research. He integrates Ribavirin and Telaprevir in his research. Telaprevir and Ribavirin are two areas of study in which he engages in interdisciplinary work.
His Genetics research focuses on subjects like Gene, which are linked to Biochemistry and Genotype. Stefan Zeuzem carries out multidisciplinary research, doing studies in Biochemistry and Gene. He merges many fields, such as Genotype and Virus, in his writings. He performs multidisciplinary study in the fields of Virus and Viral load via his papers. In his papers, he integrates diverse fields, such as Internal medicine and Pathology. In his study, he carries out multidisciplinary Pathology and Internal medicine research. His Gastroenterology study frequently draws parallels with other fields, such as Cirrhosis. His Gastroenterology research extends to the thematically linked field of Cirrhosis. Stefan Zeuzem integrates many fields, such as Hepatitis C virus and Hepacivirus, in his works.
As part of his studies on Internal medicine, Stefan Zeuzem often connects relevant areas like Adverse effect. His work on Gastroenterology is being expanded to include thematically relevant topics such as Portal hypertension. His research on Virus often connects related areas such as Chronic hepatitis. His multidisciplinary approach integrates Cirrhosis and Hepatocellular carcinoma in his work. Stefan Zeuzem combines Hepatocellular carcinoma and Cirrhosis in his research. His study on Virology is mostly dedicated to connecting different topics, such as Outbreak. As part of his studies on Outbreak, he often connects relevant subjects like Virology. His Hepatitis C virus study frequently links to adjacent areas such as Sofosbuvir. Stefan Zeuzem undertakes interdisciplinary study in the fields of Sofosbuvir and Ribavirin through his works.
Hepatitis C virus, Hepatitis a virus and Hepatitis B virus are the areas that his Virus study falls under. Stefan Zeuzem brings together Hepatitis C virus and Hepatitis C to produce work in his papers. He integrates Hepatitis C with Viral hepatitis in his study. In his research, he undertakes multidisciplinary study on Viral hepatitis and Hepatitis B. His work often combines Hepatitis B and Hepatitis B virus studies. His Virus research extends to Hepatitis a virus, which is thematically connected. His research on Hepatitis A and Acute hepatitis is centered around Hepatitis. Stefan Zeuzem brings together Hepatitis A and Hepatitis to produce work in his papers. His Cohort study study spans across into areas like Prospective cohort study and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sorafenib in Advanced Hepatocellular Carcinoma
Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard.
The New England Journal of Medicine (2008)
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Hadziyannis Sj;Sette H;Morgan Tr;Balan.
Annals of Internal Medicine (2004)
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)
Thierry Poynard;Patrick Marcellin;Samuel S Lee;Christian Niederau.
The Lancet (1998)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie.
The New England Journal of Medicine (2011)
Treatment of HCV Infection by Targeting MicroRNA
Harry L A Janssen;Hendrik W Reesink;Eric J Lawitz;Stefan Zeuzem.
The New England Journal of Medicine (2013)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon;Stuart C. Gordon;Eric Lawitz;Patrick Marcellin.
The New England Journal of Medicine (2011)
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
Richard Moreau;Rajiv Jalan;Pere Gines;Marco Pavesi.
Gastroenterology (2013)
Telaprevir for retreatment of HCV infection.
Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz.
The New England Journal of Medicine (2011)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier.
The New England Journal of Medicine (2014)
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection European Association for the Study of the Liver ⇑
Markus Peck;Antonio Craxi;Michael Fried;Stefan Zeuzem.
(2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Goethe University Frankfurt
Goethe University Frankfurt
Hannover Medical School
Hannover Medical School
New York University
Queen Mary University of London
Université Paris Cité
The University of Texas at Austin
Johns Hopkins University School of Medicine
Goethe University Frankfurt
University of Maryland, College Park
University of Washington
Kyushu University
Kyoto Pharmaceutical University
KU Leuven
University of Nantes
Czech Academy of Sciences
University of Dundee
University of Oregon
Institute Curie
Tohoku University
University of California, Riverside
Federal University of Toulouse Midi-Pyrénées
Academia Sinica
St. Jude Children's Research Hospital
National University of Singapore